Premium
Spruce Biosciences Inc (SPRB)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Show more
CAHmelia-204 Study of 200mg Once-Daily (QD) Tildacerfont in Adult Congenital Adrenal Hyperplasia (CAH) Did Not Achieve Primary Endpoint of Glucocorticoid (GC) Reduction Dose-Ranging Data from...
Topline Data from CAHmelia-204 Study of Tildacerfont in Adult Congenital Adrenal Hyperplasia (CAH) Anticipated in December 2024 Topline Data from CAHptain-205 Study of Tildacerfont in Adult and...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0482 | 12.6144988223 | 0.3821 | 0.439 | 0.365 | 546494 | 0.40171406 | CS |
| 4 | -0.1123 | -20.6966457796 | 0.5426 | 0.574 | 0.365 | 929492 | 0.45599028 | CS |
| 12 | -0.0097 | -2.20454545455 | 0.44 | 0.608 | 0.365 | 559066 | 0.48652122 | CS |
| 26 | -0.1147 | -21.0458715596 | 0.545 | 0.608 | 0.365 | 483139 | 0.48594225 | CS |
| 52 | -2.1497 | -83.3217054264 | 2.58 | 5.95 | 0.365 | 683158 | 1.1177144 | CS |
| 156 | -3.2197 | -88.2109589041 | 3.65 | 5.95 | 0.365 | 523619 | 2.14037885 | CS |
| 260 | -16.5697 | -97.4688235294 | 17 | 35.6 | 0.365 | 548910 | 3.28795644 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
